How to pay the annual fee for utility model patent?

Legal analysis: first, there is no fee reduction filing procedure or the fee reduction filing fails: 1 year 3: 600 yuan/year; Years 4-6: 900 yuan/year; 7th-8th year: 1200 yuan/year; No.9-No.65438 +00: 2000/ year. 2. The filing procedures for fee reduction are qualified (by 85%): 1 year 3: 90 yuan/year; 4-6 years: 135 yuan/year; 7th-8th year: 180 yuan/year; 9th-10/0,300/year. The annual fee for utility model patents must be paid on time. If the patentee fails to pay the annual fee and late fee in full as required, the patent right shall be terminated from the date of expiration of the previous year.

Legal basis: People's Republic of China (PRC) Patent Law.

Article 40 If the application for a patent for utility model or design is not found to be rejected after preliminary examination, the administrative department for patent in the State Council shall make a decision to grant the patent right for utility model or design, issue the corresponding patent certificate, and register and announce it at the same time. The patent right for utility model and the patent right for design shall take effect as of the date of announcement.

Article 42 From the date of filing, the term of patent right for invention is 20 years, that for utility model is 10 year, and that for design is 15 year. Where a patent for invention is granted for four years from the date of application for a patent for invention and three years from the date of request for substantive examination, the patent administration department of the State Council shall, at the request of the patentee, compensate for the unreasonable delay of the invention patent in the process of authorization, except for the unreasonable delay caused by the applicant. In order to compensate for the time occupied by the review and approval of new drugs, the patent administration department of the State Council shall compensate the patentee for the patent term of new drug-related invention patents that have been approved for listing in China. The compensation period shall not exceed five years, and the total effective patent right period after the new drug is approved for marketing shall not exceed fourteen years.